Diabetes drug tested to curb alcohol cravings
NCT ID NCT05892432
Summary
This study tested whether a medication called semaglutide (brand name Rybelsus), which is used for diabetes and weight loss, could help people with alcohol use disorder. Fifty adults seeking treatment for their drinking were randomly assigned to take either the real medication or a placebo pill for eight weeks. Researchers measured if the drug was safe for this group and if it reduced cravings for alcohol and the amount people drank.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.